Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology. Having examined the ...

Health-care companies slid after a profit warning from Eli Lilly. Shares of the obesity ... its stake in British over-the-counter health-care products purveyor Haleon. The largest pharmacy-benefit ...

Drugmaker Eli Lilly & Co is announcing a temporary shortage of two of its insulin products. "The 10 mL [millilter ... option ...

Ricks, Lilly chair and CEO. "The rest of our medicines performed within our expectations." "2024 was a pivotal and highly successful year for Lilly, and we expect to continue our momentum in 2025 ...

The Tempo pen is currently compatible with three of Lilly's insulin products, including Humalog ... head of connected care for Lilly Diabetes. "Using the learnings from early adopters of Tempo ...

Lilly seeks to protect interests in compounded ... Brendan Pierson reports on product liability litigation and on all areas of health care law. He can be reached at brendan.pierson@ ...

A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news straight to your inbox ... a likely deal-friendly Trump administration. Eli ...

through existing Distribution and Promotion Agreements with Lilly, India. “The Huminsulin range of products is indicated for the treatment of type 1 and type 2 diabetes mellitus to improve blood ...